SCM
CNTA

Sio Capital Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Sio Capital Management’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-756,891
Closed -$4.9M – 46
2023
Q3 		$4.9M Sell
756,891
-120,302
-14% -$823K 1.52% 21
2023
Q2 		$5.43M Buy
877,193
+529,324
+152% +$2.51M 1.38% 19
2023
Q1 		$1.34M Buy
+347,869
New +$1.27M 0.66% 26

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Sio Capital Management's CNTA Position: Q4 2023 in Review

Sio Capital Management sold out of Centessa Pharmaceuticals (CNTA) in Q4 2023, closing a stake of 756,891 shares — an estimated $4.9M sold.

Sio Capital Management first reported a position in CNTA in Q1 2023 and held it in 3 quarters. The position peaked at $5.43M in Q2 2023. 58 funds tracked by Wall St. Rank hold CNTA as of Q4 2023.

  • Sio Capital Management reported no remaining Centessa Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Sio Capital Management sold 756,891 Centessa Pharmaceuticals shares in Q4 2023, an estimated $4.9M.
  • Sio Capital Management first reported a position in Centessa Pharmaceuticals in Q1 2023 and held it in 3 quarters.
  • Sio Capital Management's Centessa Pharmaceuticals position peaked at $5.43M in Q2 2023.
  • 58 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q4 2023.

Based on Sio Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.